Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Cash from Financing Activities (2016 - 2026)

Cartesian Therapeutics (RNAC) has disclosed Cash from Financing Activities for 12 consecutive years, with $15.7 million as the latest value for Q1 2026.

  • For Q1 2026, Cash from Financing Activities rose 295.28% year-over-year to $15.7 million; the TTM value through Mar 2026 reached $15.6 million, down 86.67%, while the annual FY2025 figure was -$8.1 million, 104.78% down from the prior year.
  • Cash from Financing Activities hit $15.7 million in Q1 2026 for Cartesian Therapeutics, up from -$52000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $124.5 million in Q3 2024 and bottomed at -$24.8 million in Q3 2023.
  • Average Cash from Financing Activities over 5 years is $12.6 million, with a median of $380500.0 recorded in 2022.
  • Year-over-year, Cash from Financing Activities crashed 4150.49% in 2023 and then surged 28779.87% in 2024.
  • Cartesian Therapeutics' Cash from Financing Activities stood at $612000.0 in 2022, then skyrocketed by 2200.82% to $14.1 million in 2023, then tumbled by 94.44% to $783000.0 in 2024, then crashed by 106.64% to -$52000.0 in 2025, then soared by 30236.54% to $15.7 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $15.7 million, -$52000.0, and -$38000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.